July 20 (Reuters) - GlaxoSmithKline Plc is considering a break-up of the group after investors pressed the company’s board to spin off its consumer division, the Financial Times reported on Friday.
GSK Chairman Philip Hampton has been in discussions with the group's biggest shareholders about the creation of a standalone pharma and vaccines company in the medium term, the FT reported, citing sources. on.ft.com/2mwBuYT
GSK did not respond to a request for comment outside regular business hours. (Reporting by Kanishka Singh in Bengaluru, editing by Louise Heavens)